# Swift Onset, Swift Recovery: Unusual Nonrheumatic Myocarditis in a Young Adult Post Group A Streptococcal Pharyngitis

**Authors:** Andres Rios, Colby Wood, Ricardo Isaiah Garcia, Emily C. Mitchell, Jacob Nichols

PMC · DOI: 10.1155/2024/4942739 · Case Reports in Infectious Diseases · 2024-08-12

## TL;DR

A young adult developed and recovered quickly from nonrheumatic myocarditis after a strep throat infection, highlighting the need for prompt diagnosis and treatment.

## Contribution

This case report presents an atypical and rapid-onset nonrheumatic myocarditis case in a young adult post-strep throat.

## Key findings

- Nonrheumatic myocarditis can occur rapidly in young adults following Group A streptococcal pharyngitis.
- Amoxicillin and anti-inflammatory therapy effectively managed the patient's symptoms.
- Timely clinical intervention is crucial for atypical myocarditis presentations.

## Abstract

This case report highlights the unusual presentation and management of nonrheumatic myocarditis in a 24-year-old male, an age demographic not commonly associated with myocardial complications following Group A streptococcal pharyngitis. The patient, devoid of any prior medical history, manifested symptoms one day after being diagnosed with Group A streptococcal pharyngitis, a stark contrast to the typical progression of myocardial complications. The swift onset of symptoms and the patient's subsequent clinical presentation necessitated a comprehensive diagnostic approach. The patient's symptoms were successfully alleviated with amoxicillin and anti-inflammatory therapy, underscoring its potential efficacy in managing nonrheumatic myocarditis. This case serves as a poignant reminder of the importance of maintaining a broad differential diagnosis, especially in atypical presentations, and the pivotal role of timely clinical intervention. The insights from this report contribute to the broader understanding of nonrheumatic myocarditis, emphasizing the significance of tailored diagnostic and therapeutic strategies to ensure optimal patient outcomes.

## Linked entities

- **Chemicals:** amoxicillin (PubChem CID 33613)
- **Diseases:** myocarditis (MONDO:0004496)

## Full-text entities

- **Diseases:** myocardial complications (MESH:D008107), Myocarditis (MESH:D009205), inflammatory (MESH:D007249)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11333128/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11333128/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC11333128/full.md

---
Source: https://tomesphere.com/paper/PMC11333128